losartan has been researched along with h 89 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bevilaqua, LR; Cammarota, M; Dunkley, PR; Rostas, JA | 1 |
Mello-Aires, M; Musa-Aziz, R; Oliveira-Souza, M | 1 |
Chi, YF; Li, HH; Liu, Y; Qin, XY; Yan, B; Zeng, XJ; Zhang, YL | 1 |
4 other study(ies) available for losartan and h 89
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzylamines; Butadienes; Cattle; Cells, Cultured; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Isoquinolines; Losartan; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Proto-Oncogene Proteins pp60(c-src); Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Ribosomal Protein S6 Kinases; src-Family Kinases; Sulfonamides | 2001 |
Signaling pathways in the biphasic effect of ANG II on Na+/H+ exchanger in T84 cells.
Topics: Amiloride; Angiotensin II; Calcium; Cell Line, Tumor; Cell Size; Colon; Colonic Neoplasms; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Hydrogen-Ion Concentration; Isoquinolines; Losartan; Signal Transduction; Sodium-Hydrogen Exchangers; Staurosporine; Sulfonamides | 2005 |
Angiotensin II Regulates Th1 T Cell Differentiation Through Angiotensin II Type 1 Receptor-PKA-Mediated Activation of Proteasome.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Bortezomib; Cell Differentiation; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Dual Specificity Phosphatase 1; Humans; Interferon-gamma; Interleukin-2; Isoquinolines; Jurkat Cells; Losartan; Proteasome Endopeptidase Complex; Protein Subunits; Receptor, Angiotensin, Type 1; Signal Transduction; STAT1 Transcription Factor; Sulfonamides; T-Lymphocytes; Ubiquitination | 2018 |